Mature tertiary lymphoid structure is a specific biomarker of cancer immunotherapy and does not predict outcome to chemotherapy in non-small-cell lung cancer
Maxime Brunet, Amandine Crombé, Sophie Cousin, Lucile Vanhersecke, François Le Loarer, Alban Bessede, Antoîne Italiano
Topics & Concepts
MedicineLung cancerImmunotherapyChemotherapyOncologyBiomarkerCancer immunotherapyCancerCancer researchInternal medicineBiologyBiochemistryCancer Immunotherapy and BiomarkersImmune Cell Function and InteractionImmunotherapy and Immune Responses